The Food and Drug Administration (FDA) has approved several new drugs for treating psoriatic arthritis in recent years. (2024). Efficacy and safety of biologics for psoriasis and psoriatic
Skyrizi (Risankizumab) - NICE approves new treatment for psoriatic arthritis The injectable treatment gets approval for psoriatic arthritis in
Treatments for Rheumatoid Arthritis and Psoriatic Arthritis new and emerging drug therapies for treatment of rheumatoid arthritis (RA).
A review of new oral JAK inhibitor medications for the treatment of refractory rheumatoid arthritis and psoriatic arthritis
A new study will look at the impact of new drugs on people with psoriatic arthritis. A large UK-wide study examining the impact of
The U.S. Food and Drug Administration (FDA) approved three new drugs between 20 for use in psoriatic arthritis: Ustekimumab Biologic ustekinumab ( Stelara ) was approved in 2024 for the treatment of moderate to severe psoriatic arthritis in adult patients.
The U.S. Food and Drug Administration (FDA) approved three new drugs between 20 for use in psoriatic arthritis: Ustekimumab Biologic ustekinumab ( Stelara ) was approved in 2024 for the treatment of moderate to severe psoriatic arthritis in adult patients.
Psoriatic arthritis is arthritis associated with psoriasis. Clinical trials are very important in the development of new treatments for psoriatic arthritis. Newer drug treatments for
A review of new oral JAK inhibitor medications for the treatment of refractory rheumatoid arthritis and psoriatic arthritis
Comments